Metraipolis › archive › dc_cb54592cdbdd

Emerging Nanozyme Strategies for Precision Breast Cancer Treatment — Europe PMC PMID:41144769

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41144769
DOI: 10.1002/advs.202514085
License (as archived): solo-consultazione
Archived: 2026-11-09T00:44:26.229Z
SHA-256 of the archived text: d37298e10884587ab85c9afadca355c91cf67a74996ac04c60c3e45bdd5ab75f
Stable URL of this page: https://metraipolis.com/documento/dc_cb54592cdbdd

How to cite

Emerging Nanozyme Strategies for Precision Breast Cancer Treatment — Europe PMC PMID:41144769 — Europe PMC (en), https://europepmc.org/article/MED/41144769 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb54592cdbdd (Metraipolis archive dc_cb54592cdbdd, sha256 d37298e10884587ab85c9afadca355c91cf67a74996ac04c60c3e45bdd5ab75f)

BibTeX

@misc{dccb54592cdbdd,
  title = {Emerging Nanozyme Strategies for Precision Breast Cancer Treatment — Europe PMC PMID:41144769},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41144769},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb54592cdbdd; sha256 d37298e10884587ab85c9afadca355c91cf67a74996ac04c60c3e45bdd5ab75f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41144769. Agents can read the archived copy with the MCP tool read_document.